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0022-2836 © 2008 Elsevier Ltd. Open accAmyloid is a highly ordered form of aggregate comprising long, straight
and unbranched proteinaceous fibrils that are formed with characteristic
nucleation-dependent kinetics in vitro. Currently, the structural molecular
mechanism of fibril nucleation and elongation is poorly understood. Here,
we investigate the role of the sequence and structure of the initial
monomeric precursor in determining the rates of nucleation and elongation
of human β2-microglobulin (β2m). We describe the kinetics of seeded and
spontaneous (unseeded) fibril growth of wild-type β2m and 12 variants at
pH 2.5, targeting specifically an aromatic-rich region of the polypeptide
chain (residues 62–70) that has been predicted to be highly amyloidogenic.
The results reveal the importance of aromatic residues in this part of the
β2m sequence in fibril formation under the conditions explored and show
that this region of the polypeptide chain is involved in both the nucleation
and the elongation phases of fibril formation. Structural analysis of the
conformational properties of the unfolded monomer for each variant using
NMR relaxation methods revealed that all variants contain significant non-
random structure involving two hydrophobic clusters comprising regions
29–51 and 58–79, the extent of which is critically dependent on the sequence.
No direct correlation was observed, however, between the extent of non-
random structure in the unfolded state and the rates of fibril nucleation and
elongation, suggesting that the early stages of aggregation involve
significant conformational changes from the initial unfolded state. Together,
the data suggest a model for β2m amyloid formation in which structurally
specific interactions involving the highly hydrophobic and aromatic-rich
region comprising residues 62–70 provide a complementary interface that is
key to the generation of amyloid fibrils for this protein at acidic pH.© 2008 Elsevier Ltd. Open access under CC BY license.Keywords: β2-microglobulin; amyloid; NMR relaxation; unfolded state;
aggregation kineticsEdited by C. R. MatthewsIntroduction
More than 20 disorders, including Alzheimer's
and Creutzfeldt–Jacob diseases, are known to beess:
oglobulin; ThT,
ingle quantum
tibility complex; EM,
ess under CC BY license.linked with the deposition of insoluble amyloid
aggregates.1 Amyloid is a highly ordered form
of aggregate, comprising long, straight and un-
branched proteinaceous fibrils that are thought to
be formed as a result of protein misfolding.2 Such
fibrils have been shown to have a common cross-β
structure in which polypeptide β-strands are
arranged in a perpendicular fashion with respect
to the fibril long axis.3,4 It has been observed
that many proteins, including some that are not
involved in any known disease, can also form
amyloid-like fibrils in vitro under appropriate
conditions.2 This has led to the hypothesis that
252 β2m Amyloid Formation in Vitrothe ability to form amyloid fibrils is a generic
feature of polypeptide chains, although the pro-
pensity for this can be greatly affected by the
primary sequence.5 The formation of amyloid-like
fibrils in vitro occurs with characteristic kinetics
wherein a lag phase, involving the formation of
a high-energy nucleus, precedes a period of exponen-
tial growth that corresponds to fibril elongation.6
Despite an increasing number of studies examining
the influence of changes in the amino acid sequence
on the propensity of different peptides and proteins
to form amyloid fibrils,7 the structural molecular
events that occur during nucleation and elongation
remain unresolved.
Here, we describe a series of experiments that
aims to elucidate the influence of the primary
sequence and the structural properties of the initial
unfoldedmonomer on the determination of the rates
of nucleation and elongation of the amyloidogenic
protein, human β2-microglobulin (β2m). β2m is the
major protein component of amyloid plaques found
in patients suffering from dialysis-related amyloi-
dosis (reviewed by Radford et al.8). Native β2m
contains 100 residues (∼12 kDa) and has a seven-
stranded β-sandwich fold stabilised by a single
disulphide bond linking residues 25 and 80 that is
typical of the immunoglobulin superfamily.9 This
bond has been shown to remain intact in fibrils
ex vivo and to be required for the formation of long,
straight amyloid-like fibrils in vitro.10–13 A number
of studies have shown that fibril assembly from β2m
occurs rapidly under acidic conditions in vitro.14–16
Thus, at pH 2.5, β2m spontaneously and rapidly
assembles in the absence of fibrillar seeds to form
amyloid-like fibrils with N90% yield, with morpho-
logical and tinctorial properties characteristic of
amyloid formed in vivo.17 The fibrils formed under
these conditions are long, straight and twisted; bind
the dye thioflavin-T (ThT); display apple-green
birefringence in the presence of Congo red when
viewed under cross-polarised light; and bind serum
amyloid protein, glycosaminoglycans, amyloid-spe-
cific antibodies and other factors known to be
associated with amyloid in vivo.14,17,18 These fibrils
also give rise to an X-ray fibre diffraction pattern
consistent with a cross-β fold.17 The growth kinetics
under these conditions are also typical of the
formation of amyloid fibrils, wherein an elongation
phase is preceded by a lag phase, which can be
removed by addition of fibrillar seeds.19 β2m also
forms fibrils with a short, curvilinear morphology at
acidic pH in buffers at high ionic strength.14 These
fibrils form rapidly through a non-nucleated
mechanism, on a pathway parallel to that which
results in the formation of long, straight fibrils by
nucleated growth.20
Previous NMR studies have indicated that β2m is
highly unfolded in the low-pH conditions com-
monly used to initiate the nucleated growth of fibrils
in vitro.11,21 Akin to the acid-denatured states of
other proteins, T2 relaxation experiments have
indicated that β2m contains significant non-random
structure at pH 2.5, involving two hydrophobicclusters that are stabilised by the disulphide bridge
connecting Cys25 and Cys80.21 These hydrophobic
clusters involve residues 29–51 and 58–79, the latter
of which is highly enriched in aromatic amino acids
and has previously been highlighted as one of the
most aggregation-prone regions of the sequence
based on studies of synthetic peptides spanning all
seven β-strands in the native state,22 as well as by
several prediction algorithms.23–25
To investigate the role of residues 62–70 in the
formation of amyloid fibrils from full-length β2m in
vitro, and particularly the influence of the highly
aromatic nature of this part of the sequence in fibril
growth, we have made a number of substitutions
focussed on this region of the polypeptide sequence.
By developing assays capable of reliable analysis of
the rates of nucleation and elongation, we determine
the role of individual residues in this region of the
polypeptide sequence in these fibril formation
processes. The results demonstrate a key role of
aromatic residues in this part of the protein in both
fibril nucleation and elongation. By comparing the
rates obtained with those predicted by algorithms
based on the simple physicochemical properties of
the polypeptide chain, and by taking into considera-
tion the role of the structure of the initial unfolded
state, we suggest a mechanism for β2m amyloid
assembly involving a partially structured intermedi-
ate in which aromatic residues in the region 62–70
form at least one key interacting surface.
Results
Role of individual residues in residual structure
in the acid-unfolded state
One of the most striking characteristics of the
region comprising residues 62–70 in β2m is its high
content of aromatic amino acids. Thus, of the nine
residues that comprise this region, five are aromatic
(Fig. 1a). This feature possibly rationalises the
predicted high amyloidogenicity of this region of
the protein23–27 (Fig. 1b) and the ability of synthetic
peptides encompassing this region to rapidly form
amyloid fibrils in vitro.22,28 To ascertain whether the
aromatic character of residues 62–70 is important in
the aggregation process of intact β2m under acidic
conditions in vitro, eight variants were created in this
region of the protein, and their effect on the kinetics
of aggregation was monitored using the fluores-
cence of ThT as a probe of fibril formation.
Modifications involved substituting aromatic resi-
dues with aliphatic side chains (F62A, Y66A, Y67A
and F70A; Fig. 1a) to probe the effect of aromaticity
on amyloid formation, as well as the introduction of
a single charged amino acid in a central position in
this region (L65R)—a feature predicted to be
unfavourable for aggregation.5,29,30 In addition,
Tyr66 was substituted with three different residues
(Y66A, Y66E and Y66S) to determine whether
changes in the kinetics of fibril formation could be
related to the chemical properties of the introduced
Fig. 1. (a) Sequence of human β2m, with native secondary structural elements indicated. The position of the disulphide
bond in the sequence is highlighted. Amino acids that were targeted in this study are highlighted in red, and the
alterations made are show in green. (b) TANGO prediction for β-aggregation of the β2m sequence,
23 indicating that the
region corresponding to native β-strand E (residues 62–70) is highly aggregation-prone.
253β2m Amyloid Formation in Vitroside chain.23,26,30 Finally, three aromatic residues
were removed simultaneously from the variant
F62AY63AY67A. This variant has been createdFig. 2. 1H–15N HSQC spectra of (a) wild-type, (b) F62A and
blue, respectively (many of which correspond to residues in t
wild-type protein. Relaxation rates (R2) for (d) wild-type, (e) F
using a random coil model that contains two regions of non-ra
(see Materials and Methods).21 The fit for wild-type β2m is alhitherto and, most interestingly, shown to greatly
disrupt residual structure in the acid-unfolded
state,21 providing an opportunity to assess the role(c) L65R β2m. In (b) and (c), the peaks circled in green and
he region 62–70), are not detectable in the spectrum of the
62A and (f) L65R β2m. The data in (d)–(f) have been fitted
ndom structure, in addition to the single disulphide bond
so shown in red in (e) and (f) to facilitate comparison.
Fig. 3. Average R2 rates for all of the variants studied
here. ‘Trip’ refers to the triple mutant F62AY63AY67A. (a)
R2 values for the hydrophobic cluster centred at residue 70
for each variant, obtained from average values for
residues 61, 68, 73 and 75. (b) R2 values for the
hydrophobic cluster centred at residue 40 for each variant
(based on average R2 values for residues 33, 34, 41 and 43
that lie in this cluster). (c) Interaction between the two
clusters demonstrated by plotting the average R2 values
for each cluster in each variant against each other.
254 β2m Amyloid Formation in Vitroof structure in the acid-unfolded monomeric pre-
cursor in determining aggregation rates. Finally, to
investigate whether any changes in aggregation
kinetics observed are specific to residues 62–70 or
merely reflect a general alteration in the solubility
or hydrophobicity of the polypeptide chain, var-
iants containing amino acid substitutions that
decrease hydrophobicity (I7A), decrease or increase
aromaticity (F30A and L40F) or introduce charge
(L40R) were made in other regions of the protein
(Fig. 1a).
To determine the effect of the amino acid sub-
stitutions on the structure and dynamics of the
unfolded state of β2m at pH 2.5 (the initial starting
point of the aggregation reactions described below),
1H–15N heteronuclear single quantum coherence
(HSQC) spectra of wild-type β2m and the 12
variants were acquired, and the relaxation proper-
ties of individual resonances were determined. The
resulting spectra indicated that all 13 proteins are
highly unfolded at pH 2.5, with the majority of
residues giving rise to intense resonances with little
chemical shift dispersion (Fig. 2a–c). Consistent with
previous studies of the wild-type protein at this
pH,11,21 measurement of the R2 relaxation rates
revealed a number of resonances that are signifi-
cantly broadened, whilst others are broadened
beyond detection. These cluster into two regions
of the sequence involving residues ∼29–51 and
∼58–79, consistent with these regions deviating
from a random structure under these conditions
(Fig. 2d–f). Akin to the properties of the wild-type
protein (Fig. 2a and d),21 residues 62–70 in all of
the variants (corresponding to β-strand E in native
β2m; Fig. 1a) show the most broadened resonances,
whilst the second group of residues (29–51) also
displays significant broadening, consistent with the
presence of two hydrophobic clusters in the acid-
unfolded state. Importantly, substitution of resi-
dues in the region 62–70 not only affects the
dynamics within its own cluster but also perturbs
those of the residues in the cluster centred on
residue 40, indicating that these two regions are
mutually interacting (Fig. 3a–c). By contrast, Ile7, a
residue that is highly dynamic in the acid-unfolded
state and is not involved in the residual structure,
has little effect on the dynamics of either cluster.
Finally, and by contrast with the small to moderate
changes in R2 observed when single point mutants
are introduced into the region 62–70, reducing
the aromatic content of this region substantially
by replacing three aromatic residues with alanine
simultaneously (F62AY63AY67A, hereinafter re-
ferred to as the triple mutant) results in the
greatest reduction in R2 values in both clusters
(Fig. 3a and b). Therefore, over the range of amino
acid changes introduced, hydrophobic clustering
involving residues 62–70 has been titrated from a
behaviour similar to that of wild-type β2m (e.g.,
I7A), through proteins with partially disrupted
clusters (as is the case with most of the single point
variants in the region 62–70), to the triple mutant
that is the most highly dynamic species of this set(Fig. 3a), enabling the importance of residual
structure in this region for amyloid assembly to
be explored.
The role of aromatic interactions in fibril
elongation
The fibril elongation kinetics of each of the
variants of β2m created was next monitored at
255β2m Amyloid Formation in VitropH 2.5 using ThT fluorescence. Experiments per-
formed in parallel using intrinsic tryptophan
fluorescence or fluorescence anisotropy confirmed
that ThT fluorescence reflects the formation of
amyloid-like fibrils, since similar rates of fibrillation
are observed independent of the assay used (data
not shown). Multiple samples of the monomeric
state of each variant at pH 2.5 were set up
simultaneously, added to fibril seeds formed from
the wild-type protein (see Materials and Methods),
and the apparent elongation kinetics of each
sample was recorded using a 96-well plate reader
at 25 °C. In each case, the apparent elongation rate
obtained with the wild-type protein was recorded
concurrently and used to normalise the data
obtained for each variant. The resulting data (Fig.
4a) revealed that 10 of the 12 variants created are
able to elongate wild-type fibril seeds under these
conditions, resulting in fibrils that are morphologi-
cally indistinguishable from those formed from the
wild-type protein, as expected for templated
growth of proteins with high sequence identity.31–
33 Most importantly, however, clear differences in
the apparent rate of elongation were observed for
different variants, dependent upon the site or the
type of amino acid substitution made. Thus, some
variants showed kinetics similar to that of wild-
type β2m (e.g., I7A, F30A and L40F), whilst othersresulted in apparent elongation rates that were
substantially reduced (Figs. 4a and 5a). Most
strikingly, all of the variants containing amino
acid substitutions that remove an aromatic amino
acid in the region 62–70 reduced the apparent rate
of elongation significantly, whilst similar changes
made elsewhere in the sequence resulted in little
change in the rates (e.g., compare the data for F62A
and F70A with the data for F30A; Figs. 4a and 5a).
The data suggest, therefore, that aromatic residues
in the region 62–70 form an interacting interface
involved in the elongation of fibril seeds. Consis-
tent with this view, the most dramatic effect of the
12 amino acid substitutions introduced was
obtained with the variant L65R, where a single
substitution in this region abolishes the ability of
this protein to elongate wild-type seeds under the
conditions employed (Figs. 4a and 5a). Importantly,
the same type of substitution made elsewhere
(L40R) had a much smaller effect, reinforcing the
view that residues 62–70 play a key role in fibril
elongation. Finally, whilst incubation of the triple
mutant results in no increase in ThT fluorescence
monitored over 5 h (Fig. 4a), a small but
significant increase in ThT fluorescence was
observed when the reaction was monitored over
an extended time period. The rate observed,
however, mirrors that observed in the absenceFig. 4. (a) Apparent elongation
rates of β2m variants analysed
using seeded fibril growth moni-
tored by ThT fluorescence. Variants
displaying apparent elongation
kinetics similar to those of wild-
type β2m are shown in red, those
with intermediate apparent rates
are shown in green and those with
the slowest apparent rates are indi-
cated in blue. Negative-stain EM
images, taken after 24 h, for three
example variants are shown on the
right, with scale bars representing
200 nm. (b) Example ThT traces of
spontaneous fibril formation for
different variants of β2m. Data are
presented for wild-type β2m (red), a
variant with intermediate kinetics
(Y67A; green) and a variant with a
long lag time (F62A; blue). Nega-
tive-stain EM images for the fibrils
formed from these three variants
are shown on the right, with the
scale bar representing 200 nm.
Fig. 5. Comparison of fibril formation rates with
structural properties of the initial unfolded state. (a)
Relative apparent elongation rates (taken from 1/t[50%]
value) determined using seeded growth assays normalised
to the data for wild-type β2m. The fastest rates are shown
in red, intermediate rates are shown in green and the
slowest rates are indicated in blue. (b) Normalised 1/lag
times determined using spontaneous fibril growth experi-
ments, coloured as in (a). (*) Not all of the reactions
containing L65R resulted in fibril formation over the 75-h
period studied. In these cases, the end point of the
experiment (75 h) was taken as the lag time. The data
shown, therefore, are an underestimate of the true lag
time. (c) Rates of T2 relaxation for the hydrophobic cluster
involving residues 62–70 calculated using an average of
the values obtained for residues 61, 68, 73 and 75 for each
variant. The bars are coloured according to the scheme
used in (a) and (b).
256 β2m Amyloid Formation in Vitroof fibril seeds (see below), indicating that the
removal of three aromatic residues from this region
of the polypeptide chain results in a monomer that is
unable to elongate wild-type seeds under these
conditions.Mutational effects on the lag time
Nucleation of amyloid fibril growth is thought to
involve the formation of an energetically unfavour-
able nucleus, which then permits rapid elongation
and formation of fibrillar species.6 The development
of assay conditions that permit the formation of
fibrils with reproducible kinetics without any
evidence for amorphous aggregation provides an
opportunity to determine the role of individual
residues in the nucleation process. To determine the
role of aromatic residues in the region 62–70 in the
nucleation of β2m fibril formation, the length of the
lag time in the formation of amyloid-like fibrils of
wild-type β2m and the 12 variants created was
measured using an assay in which spontaneous
assembly was monitored in the absence of fibril
seeds (see Materials and Methods). Once again,
multiple replicate samples of the wild-type protein
and each variant were monitored in parallel,
allowing the average lag time for each variant to
be accurately measured and normalised to that of
the wild-type protein. The results, shown in Figs. 4b
and 5b, revealed that all of the variants are able to
form long, straight fibrils that resemble those of the
wild-type protein in these unseeded reactions, with
lag times that vary substantially. For Y66E, however,
fibrils of different morphologies were also observed.
Thus, fibrils with the twisted rope-like structure
observed for long, straight fibrils formed from wild-
type β2m were found, mixed with a second fibril
type consisting of flat twisted ribbons. All of the
variants containing amino acid substitutions
between residues 62 and 70 resulted in a significant
increase in the lag time, except for Y66E. By contrast,
the variants involving substitutions made outside
this region, such as I7A and L40F, showed little
change in the lag time, while F30A showed a
reduction in the lag time. Again, the most dramatic
effect was observed for the variant L65R. For this
protein, 9 of the 12 replicates analysed did not result
in the formation of long, straight fibrils within the
75-h timescale of this experiment, with fibril forma-
tion for these samples instead resulting in short
curvilinear fibrils reminiscent of those formed from
the wild-type protein at high ionic strengths after
incubation for this time.17,20 Thus, the mutation
L65R substantially disfavours nucleation, leaving
open access to the competing non-nucleated assem-
bly pathway,20 resulting in the formation of curvi-
linear fibrils under these conditions. Together, the
data demonstrate that residues 62–70 play an
important role in fibril nucleation, such that remov-
ing aromatic residues or adding a single charge in
this region severely disrupts the ability of the
sequence to nucleate fibril growth.
Fibril nucleation and elongation involve similar
interacting surfaces
Previous studies of amyloid formation in vitro
using insulin, glucagon and different variants of
Aβ(1–40) as model systems have shown that the
257β2m Amyloid Formation in Vitrolength of the lag time and the apparent elongation
rate are correlated.34 To determine whether this is
the case for the variants of β2m created here, the
apparent elongation rate and the lag time for each
individual sample of each variant studied were
plotted (Fig. 6). The results revealed a clear correla-
tion between these two parameters, with reactions
with the longest lag time showing the slowest
apparent elongation rates and vice versa, implying
a common mechanism of fibril formation for all of
the variants studied (Fig. 6). Interestingly, although
a correlation between the lag time and the apparent
elongation rate is observed for β2m, quantitatively
the dataset differs from that obtained previously for
the aggregating peptide systems analysed by Fän-
drich, possibly reflecting the increased size and
complexity of β2m relative to the systems studied to
date.34 Alternatively, the difference could result
from the different growth conditions used, such as
quiescent versus agitation, with the latter being
required to create fibrils from β2m on a measurable
timescale without visible amorphous aggregation.
Role of residual structure in acid-unfolded β2m
in fibril growth
The structure in the acid-unfolded state of β2m
(reflected by the R2 value for the 62–70 cluster) and
the apparent rates of fibril nucleation and elongation
are compared in Fig. 5. Whilst the relationship
between these parameters is complex, qualitatively
clear features emerge. Thus, all of the variants that
have an average R2 value in the cluster 62–70 similar
to that of wild-type β2m result in nucleation and
apparent elongation rates akin to those of the wild-
type protein (Fig. 5, red bars). For variants with
reduced R2 values in this cluster, however, no clear
correlation is observed between the R2, the lag time
and the apparent elongation rate. For instance, Y66E
and F70A display similar relaxation rates; however,Fig. 6. Scattergram of the apparent elongation rate
versus the lag time of each individual spontaneous fibril
growth experiment for all of the variants studied here.
The inset shows a log–log plot of the same data with a
linear fit, implying a common aggregation mechanism
for all of the variants studied. The data points are coloured
according to the same scheme as in Fig. 5.the apparent rate of fibril elongation is far greater for
Y66E. Similarly, F62A has one of the slowest rates of
elongation and nucleation, but this substitution has
only a moderate effect on the R2 values. Finally,
whilst L65R has a dramatic effect on the ability of
β2m to form amyloid fibrils, the R2 of this variant is
only moderately perturbed. Similar results have
been obtained previously for other proteins,
wherein aggregation has been shown to be favoured
by solution conditions that promote stable inter-
molecular interactions rather than inducing specific
conformational properties in a partially unfolded
state.35,36 Whilst the retention of a hydrophobic
cluster in the region 62–70 in β2m is commensurate
with rapid fibril growth, the precise effects of an
amino acid substitution thus appear to depend
critically on the type of substitution made and the
location of the amino acid substituted, suggesting
that the context of each amino acid in the polypep-
tide sequence and in the structure of the early
aggregating species plays a critical role in determin-
ing the aggregation potential of each variant.
Consistent with this conclusion, algorithms devel-
oped to predict aggregation potential or elongation
rates, assuming that self-assembly involves an
unstructured precursor in which every amino acid
contributes equally and is dependent only upon its
physicochemical properties, result in a poor predic-
tion of the aggregation rates of the 12 variants
created here (data not shown).5,29,30
Discussion
Importance of residues 62–70 in the aggregation
of β2m
The kinetic data presented above show that of the
100 residues that comprise the sequence of β2m,
residues 62–70 form at least one key interacting
surface that is important in fibril formation. We
show, using detailed kinetic analysis of fibril
formation, that altering residues to reduce hydro-
phobicity or to introduce polar side chains into this
hydrophobic region of the polypeptide chain
increases the length of the lag time and decreases
the apparent elongation rate of fibril formation,
whilst identical amino acid substitutions made
elsewhere in the protein have little effect on the
rate of fibril formation. The importance of residues
62–70 in the fibrillogenesis of β2m has been
suggested previously based on studies of synthetic
peptides corresponding to each of the seven β-
strands of native β2m, in which only the peptide
containing this sequence, equivalent to β-strand E
in the native protein, was shown to form fibrils in
isolation,22 as well as by analysis of shorter six-
residue amino acid sequences taken from this
region.28 Strikingly, despite the identification of a
stretch of only nine residues that is able to
modulate or even ablate fibril formation dependent
on its sequence, N80 residues of this 100-residue
protein are involved in the fibril core, as revealed
258 β2m Amyloid Formation in Vitroby limited proteolysis and hydrogen exchange
experiments.37,38 We show here that the aggregation
propensity of this region is conferred, at least in part,
by the unusually high content of aromatic residues
in this sequence, such that removal of a single
aromatic moiety or the introduction of a single
charge in this region has a dramatic effect on fibril
growth. Interestingly, the crystal structure of β2m in
the major histocompatibility complex (MHC) class I
complex illustrates that aromatic residues in this
region (Phe56, Trp60, Phe62 and Tyr63) form
important interactions with the α1α2 domains of
the MHC heavy chain, while Leu65 makes contact
with the α3 domain, suggesting a functional
requirement for the evolution of this sequence,
despite its high amyloid potential.39 The functional
significance of these residues is highlighted by the
fact that they are all highly conserved across β2m
sequences from many species, whilst other aromatic
amino acids found in this region of human β2m (Y66
and Y67) are not retained in other sequences.40,41 In
the CH3 domain of the Fc fragment (A342–A443)
that belongs to the same structural class of immu-
noglobulin domains as β2m, the equivalent region of
the sequence differs markedly (GSFFLYSKLTVD
and WSFYLLYYTEFT, respectively; identical resi-
dues are underlined).42 Although human β2m
contains this aggregation-prone sequence, it appears
to have developed mechanisms to avoid aggrega-
tion by burying this region in the core of the MHC
complex and, for the native monomeric protein, by
sequestering this strand within the centre of the β-
sheet involving strands A, B, E and D, such that its
full aggregation potential is not revealed.9,43 Indeed,
natively folded β2m can be incubated for extended
periods of time at millimolar concentrations (N1000
times higher than the in vivo concentration) in the
absence of seeds without detectable amyloid
formation.18,44 This therefore explains why amyloid
formation can occur under conditions that encou-
rage unfolding,14,15,45,46 whereupon residues 62–70
may become exposed and realise their fibrillogenic
potential.
Mechanisms of β2m aggregation
It has previously been observed that β2m forms
amyloid-like fibrils at pH 7 via an on-pathway
folding intermediate (Fig. 7).44 This aggregation-
prone species possesses a highly native-like struc-
ture according to chemical shift analysis of NMR
spectra, but contains a trans His31–Pro32 peptide
bond compared with the cis isomer found in native
β2m.
39 Despite analysis of this early aggregation-
prone species, the mechanism of further assembly
steps remains elusive. Interestingly, a key role for
the region encompassing residues 62–70 in the
aggregation of β2m at acidic pH is consistent with
the increased amyloidogenicity observed under
physiological conditions for the derivative contain-
ing a single cleavage of the polypeptide chain at
Lys58.48 In this variant, the aromatic-rich region of
the protein involving residues 62–70 may be lessconformationally constrained, increasing the oppor-
tunity for it to participate in intermolecular interac-
tions. How the aggregation mechanism under acidic
conditions relates to that under physiological con-
ditions is currently unresolved, and further experi-
ments will be needed to determine directly the role
of residues 62–70 in this pathway. Interestingly,
there are a large number of amino acids bearing
carboxyl groups within the 58–79 region (Asp59,
Glu69, Glu74, Asp76 and Glu77) that, whilst most
likely neutral under the acidic conditions of this
study, are presumably charged under physiological
conditions. Thus, electrostatic repulsion of these side
chains may account for the slower aggregation rates
of β2m at neutral pH.
The data presented here suggest that amyloid
formation from acid-unfolded β2m involves both
sequence and structural specificities, with indivi-
dual residues in the region 62–70 playing different
roles that depend not only on their physicochemical
properties but also on their location in the sequence
and on the structure of the self-assembling species.
Based on these data, we suggest that the initial steps
of β2m self-assembly into amyloid at pH 2.5 involve
the association of two or more hydrophobically
collapsed species, which present a specific surface
involving residues 62–70 that, by an unknown
mechanism, favours the transition of the unfolded
protein into elongation-competent species (Fig. 7).
This possibility is supported by mass spectrometric
evidence, which indicates that β2m forms amyloid-
like fibrils via small oligomeric species at low pH.49
The variants analysed here indicate that the region
corresponding to the native β-strand E plays an
important role in the nucleation and elongation of
amyloid-like fibrils from β2m under acidic condi-
tions in vitro. Determining whether other regions of
the polypeptide chain are involved in these events—
such as the B/C loop containing Phe30 that was
predicted by Kozhukh et al.50 to be key to amyloid
formation, or residues 83–89 shown by Ivanova et
al.40 to be important in fibril formation based on a
sequence comparison of human and mouse β2m—
will require further detailed mutagenesis studies to
resolve. The approach taken here, in which repro-
ducible assays for analysing the rates of nucleation
and elongation have been developed, lays the
foundation for such studies. Perhaps most impor-
tant are questions involving the nature of the
nucleation- and elongation-competent species,
including the number of aggregation-promoting
regions, their structural organisation and their size.
The data presented here suggest that similar regions
of the protein are involved in both stages of
aggregation for β2m, as has been observed pre-
viously for other proteins.34 Whether this is a
generic characteristic of amyloid formation across
protein systems and different growth conditions
remains to be resolved.
Despite progress in understanding the mechan-
isms of amyloid formation, small-molecule thera-
pies for this class of disorder still have to be
developed, especially for proteins that lack an active
Fig. 7. Schematic diagram of a possible mechanism for β2m aggregation at pH 7.0 and pH 2.5. Aggregation at pH 7.0
proceeds via a native-like intermediate.44 At pH 2.5, β2m is highly unfolded, with the residues in the region 62–70
participating in a non-native hydrophobic cluster. This is shown in the figure by circles coloured as in Fig. 5. A single
disulphide bond (yellow) links residues 25–80 and is essential for fibril formation.12 In the initial stages of fibril formation,
we propose that residues 62–70 form one key complementing surface involved in both the nucleation and the elongation
phases of fibril growth and may provide a target for therapeutic molecules to disrupt amyloid formation. Since the fibrils
formed from a native-like state at neutral pH and those formed from an acid-denatured state are morphologically
indistinguishable,47 the fibril formation pathways presumably must converge, although the point at which they do so
remains uncertain. The precise details of the size of the nucleus and the structure of the fibrils remain unresolved.
259β2m Amyloid Formation in Vitrosite that can readily be targeted for inhibitor
design.51 One approach to the development of
therapeutic agents is the use of small molecules
that specifically and efficiently inhibit the aggrega-
tion process. Indeed, a range of polyphenol mole-
cules have recently been demonstrated to be capable
of inhibiting the formation of fibrillar aggregates for
targets such as Aβ, α-synuclein, Tau, islet amyloid
polypeptide, insulin, calcitonin and prion protein.52
Interestingly, it appears that the structural proper-
ties of these small molecules contribute to their
inhibitory effect, and it has been suggested that their
ability to inhibit aggregation can be attributed to
their aromatic character, which enables interactionswith the amyloidogenic sequence.52,53 Such mole-
cules may therefore be useful for inhibiting the
aggregation of acid-unfolded β2m, based on our
observation that the aromatic-rich portion of the
β2m sequence is important in fibril formation. The
fact that at least one distinct region of β2m is key to
amyloid formation makes this part of the sequence a
possible target for designing aggregation inhibitors
(Fig. 7).54 Previously, short sequence stretches of
proteins have been targeted by self-recognition
peptidomimetic compounds that disrupt amyloid
formation.55 For instance, many groups have used
the structure-based introduction of N-methylated
peptides for proteins such as Aβ, α-synuclein and
260 β2m Amyloid Formation in Vitroislet amyloid polypeptide, which bind specifically at
self-recognition sites to develop inhibitors of amy-
loid formation for these proteins.56–58 Other peptide-
based inhibitors that are sequence-specific but
inhibit aggregation by alternative mechanisms
such as sequence alteration, insertion of β-breaker
residues and terminal modifications have been
described.55 Ultimately, the first stage of rationally
designing such an inhibitor must be target identifi-
cation. At least for acid-unfolded β2m, one such
target is the aromatic-rich region comprising resi-
dues 62–70 identified here. The production of
successful inhibitory molecules based on this target
region may not only prove useful for further
dissection of the mechanism of fibril assembly at
pH 2.5 and may also provide useful tools for the
delineation of the mechanism of fibril formation at
neutral pH and of the stages, if any, at which the
fibril formation mechanisms at acidic and neutral
pH converge.Materials and Methods
Materials
The Escherichia coli strain BL21(DE3) pLysS was obtained
from Promega. Q-Sepharose and all other reagents were
purchased from the Sigma-Aldrich Chemical Company.
Spectrapore membrane (molecular mass cutoff, 3500 Da)
was obtained from Spectrum Laboratories, Inc. Superdex
75 was purchased from Amersham Biosciences. Carbeni-
cillin was obtained from Melford Chemicals. Deuterated
solvents were obtained from Fluorochem Ltd. Oligonu-
cleotides were purchased from MWG Biotech.
Mutagenesis and protein purification
Mutagenesis was carried out using the QuikChange
site-directed kit (Stratagene) with the plasmid pINKWT as
template.14 The recombinant human β2m variants were
expressed in 15N-enriched minimal media and purified as
described.21 The proteins were shown to be N95% pure by
SDS-PAGE and N95% labelled with 15N, as determined
using electrospray ionisation mass spectrometry. The
proteins were stored at −20 °C as lyophilised powder.
Protein concentrations were calculated from A280 of the
denatured state using the coefficients determined by the
method of Gill and von Hippel.59
Kinetic analysis of fibril growth
Data were recorded using a BMG FLUOstar Optima
reader (BMG) and 96-well black-wall plates (Costar)
sealed with clear sealing film (Axygen). Samples had a
volume of 100 μl containing 100 μMThT in 25 mM sodium
acetate/25 mM sodium phosphate (pH 2.5) and 0.04%
(wt/vol) NaN3. The proteins were all dissolved at
approximately twice the final required concentration as
stock solutions in ∼5 mM HCl and centrifuged at
∼400,000g for 30 min at 10 °C. Only the upper third of
the solution was used for fibril growth experiments to
ensure that each reaction commenced with soluble
protein. These samples were confirmed to contain onlymonomeric material by analytical gel filtration and
analytical ultracentrifugation. Protein was added to each
well such that the final concentration was 89 μM for each
variant. Measurements were acquired simultaneously for
six replicates of each variant. The plate was incubated at
25 °C with orbital shaking (1 mm width, 600 rpm), and
data points were recorded every 5 min, with the
fluorescent measurements representing the average from
20 flashes. To follow ThT fluorescence, the samples were
excited at 440 nm, and the fluorescence emission was
measured at 480 nm. In the case of seeded growth, the
same protocol was followed, except that 2% (vol/vol) seed
was added to the initial reaction. The seed consisted of
wild-type β2m fibrils, formed previously at pH 2.5, that
had been fragmented by four freeze–thaw cycles and
stored at −80 °C in multiple aliquots. This ensured that the
same seeds were used for all reactions. The fibrils used as
seeds were grown using wild-type β2m (89 μM) in 25 mM
sodium acetate/25 mM sodium phosphate (pH 2.5) and
0.04% (wt/vol) NaN3 at 37 °C with shaking for 14 days
and were determined to be long, straight amyloid-like
fibrils by negative-stain electron microscopy (EM). To
obtain an independent verification of fibril growth, test
reactions were performed using conditions identical to
those described above, but the progress of fibril growth
was measured by the change in ThT fluorescence and by
intrinsic tryptophan fluorescence (with excitation at
280 nm and with emission measured at 350 nm). Both
methods showed identical kinetics, where an increase in
ThT fluorescence is associated with a concomitant
decrease in intrinsic tryptophan fluorescence.
The observed growth traces showed differences in the
final ThT fluorescence signal for the different variants, yet
usually the same final fibril yield (determined by
absorbance measurements of soluble material after cen-
trifugation) and fibril morphology. Therefore, all the data
were normalised by assuming a final ThT signal of 100%,
and the resulting curves were used to determine the lag
times and apparent rate of elongation. The lag time was
obtained by fitting a straight line to the initial slope of the
growth phase. The time at which this line intersected with
the baseline was taken as the lag time.60 Fits of the
apparent elongation rates were carried out by using only
the part of the curve corresponding to the growth phase
and by assuming exponential growth with the formula
y=A+Be(−kx). The value of k was taken as the apparent
rate of elongation. In the case of seeded growth, the
inverse of the time taken to reach 50% of the final
normalised ThT signal was used as an indication of the
apparent rate of elongation.NMR sample preparation
All NMR experiments were carried out using 5 mg/ml
15N-labelled β2m in 90% (vol/vol) H2O/10% (vol/vol)
2H2O at pH 2.5. The pH was adjusted using dilute HCl.NMR spectroscopy
NMR experiments were performed at 25 °C using a
Varian Unity Inova spectrometer operating at a 1H
frequency of 500 MHz. Gradient-enhanced 1H–15N
HSQC spectra were acquired using 128 complex points
and 16 scans per increment, with spectral widths of
4508 Hz and 1200 Hz in the 1H and 15N dimensions,
respectively.Watergate solvent suppression was used, and
all NMR data were processed using NMRPipe.61 The data
261β2m Amyloid Formation in Vitrowere apodised using a cosine bell function, followed by
zero filling and Fourier transform. The two-dimensional
spectra were analysed in NMRView.62
Backbone 15N transverse relaxation measurements
[transverse relaxation rate, R2=(T2)
−1] were carried out
as described.63 Duplicate points and the spectral noise
levels were used to obtain an estimate of the error. The R2
relaxation measurements of wild-type β2m and the
described variants were performed at 500 MHz at
pH 2.5 in dilute HCl at 25 °C using a series of 11
experiments, with mixing times ranging from 16.32 ms to
456.96 ms. The transverse relaxation data for all of the
experiments at pH 2.5 were analysed using models for
increasing complexity, as described previously.21,64,65Acknowledgements
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